Invesco Ltd. Intercept Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.99 - $18.71 $548,071 - $1.03 Million	54,862 Added 375.69%	69,465 $1.29 Million
Q2 2023 Aug 11, 2023	BUY	$9.17 - $19.29 $13,076 - $27,507	1,426 Added 10.82%	14,603 $161,000
Q1 2023 May 12, 2023	SELL	$12.53 - $21.71 $426,846 - $739,572	-34,066 Reduced 72.11%	13,177 $176,000
Q4 2022 Feb 13, 2023	BUY	$11.61 - $16.11 $215,678 - $299,275	18,577 Added 64.8%	47,243 $584,000
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $40,903 - $65,995	-3,350 Reduced 10.46%	28,666 $399,000

Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $16,732 - $29,189	-1,490 Reduced 4.45%	32,016 $442,000
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $281,893 - $375,084	21,084 Added 169.73%	33,506 $545,000
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $23,362 - $31,951	-1,636 Reduced 11.64%	12,422 $202,000
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $27,369 - $43,130	2,107 Added 17.63%	14,058 $209,000
Q2 2021 Aug 17, 2021	BUY	$15.46 - $24.5 $184,762 - $292,799	11,951 New	11,951 $239,000
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $585,758 - $1.15 Million	-12,543 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $155,687 - $382,149	3,220 Added 34.54%	12,543 $790,000
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $360,679 - $780,340	-6,288 Reduced 40.28%	9,323 $1.16 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $165,564 - $226,977	2,821 Added 22.06%	15,611 $1.04 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $215,656 - $334,645	2,773 Added 27.68%	12,790 $1.02 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $394,501 - $518,441	4,296 Added 75.09%	10,017 $1.12 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $490,804 - $723,477	5,721 New	5,721 $577,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account